Crystal Growth Inhibitors for the Prevention of L-Cystine Kidney Stones Through Molecular Design
- NY Univ.
Crystallization of L-cystine is a critical step in the pathogenesis of cystine kidney stones. Treatments for this disease are somewhat effective but often lead to adverse side effects. Real-time in situ atomic force microscopy (AFM) reveals that L-cystine dimethylester (L-CDME) and L-cystine methylester (L-CME) dramatically reduce the growth velocity of the six symmetry-equivalent {l_brace}100{r_brace} steps because of specific binding at the crystal surface, which frustrates the attachment of L-cystine molecules. L-CDME and L-CME produce L-cystine crystals with different habits that reveal distinct binding modes at the crystal surfaces. The AFM observations are mirrored by reduced crystal yield and crystal size in the presence of L-CDME and L-CME, collectively suggesting a new pathway to the prevention of L-cystine stones by rational design of crystal growth inhibitors.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1002802
- Journal Information:
- Science, Vol. 330, Issue 10, 2010; ISSN 0193-4511
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Potential Pharmacologic Treatments for Cystinuria and for Calcium Stones Associated with Hyperuricosuria
Cystine and dibasic amino acid uptake by opossum kidney cells